Top News

SARcode Bioscience Acquired By Shire

Brisbane, California-based SARcode Bioscience said Monday that it is in an acquisition deal with Shire US Holdings, the global specialty biopharmaceuticals firm. SARcode said that Shire will pay $160M plus additional, undisclosed payments based on future milestones for the company. SARcode was venture backed by Alta Partners, Clarus Ventures, Rho Ventures, Sofinnova Ventures, and Sunesis Pharmaceuticals.


 

Marketplace


blog comments powered by Disqus
 

Latest Headlines

Browse Issues